<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    3123132
   </pmid>
   <datecreated>
    <year>
     1988
    </year>
    <month>
     03
    </month>
    <day>
     04
    </day>
   </datecreated>
   <datecompleted>
    <year>
     1988
    </year>
    <month>
     03
    </month>
    <day>
     04
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2004
    </year>
    <month>
     11
    </month>
    <day>
     17
    </day>
   </daterevised>
   <article pubmodel="Print">
    <journal>
     <issn issntype="Print">
      0010-7824
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       36
      </volume>
      <issue>
       2
      </issue>
      <pubdate>
       <year>
        1987
       </year>
       <month>
        Aug
       </month>
      </pubdate>
     </journalissue>
     <title>
      Contraception
     </title>
     <isoabbreviation>
      Contraception
     </isoabbreviation>
    </journal>
    <articletitle>
     Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    </articletitle>
    <pagination>
     <medlinepgn>
      169-79
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext>
      The use-effectiveness of an intrauterine contraceptive device releasing 20 mcg of levonorgestrel daily (Lng-IUD), and of a Nova T copper-releasing IUD, were studied in a randomized, comparative multicenter trial. The Lng-IUD was inserted in 1821, and the Nova T in 937 women. The 12-month net pregnancy rate with the Lng-IUD (0.1 per hundred women) was significantly lower than that with the Nova T (0.9 per hundred). Removal rates for menstrual problems and/or pain were similar for the two methods (net rates 7.5 and 8.7, respectively). The 12-month continuation rates were 82.2 for the Nova T and 79.7 for the Lng-IUD. The reduction of the bleeding led to oligomenorrhea and amenorrhea in users of the Lng-IUD; the removal rate for these reasons was 1.4. The removal rate for hormonal side effects with the Lng-IUD was 2.4. Blood hemoglobin concentrations increased among users of the Lng-IUD and decreased among users of the Nova T. The results show that the Lng-IUD was a highly effective contraceptive method which reduced menstrual bleeding. It is a promising alternative for women desiring a highly effective method for long-term use.
     </abstracttext>
    </abstract>
    <affiliation>
     City Maternity Hospital, Helsinki, Finland.
    </affiliation>
    <authorlist completeyn="N">
     <author validyn="Y">
      <lastname>
       Luukkainen
      </lastname>
      <forename>
       T
      </forename>
      <initials>
       T
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Allonen
      </lastname>
      <forename>
       H
      </forename>
      <initials>
       H
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Haukkamaa
      </lastname>
      <forename>
       M
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Holma
      </lastname>
      <forename>
       P
      </forename>
      <initials>
       P
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Pyörälä
      </lastname>
      <forename>
       T
      </forename>
      <initials>
       T
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Terho
      </lastname>
      <forename>
       J
      </forename>
      <initials>
       J
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Toivonen
      </lastname>
      <forename>
       J
      </forename>
      <initials>
       J
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Batar
      </lastname>
      <forename>
       I
      </forename>
      <initials>
       I
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Lampe
      </lastname>
      <forename>
       L
      </forename>
      <initials>
       L
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Andersson
      </lastname>
      <forename>
       K
      </forename>
      <initials>
       K
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <publicationtypelist>
     <publicationtype>
      Clinical Trial
     </publicationtype>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Randomized Controlled Trial
     </publicationtype>
    </publicationtypelist>
   </article>
   <medlinejournalinfo>
    <country>
     UNITED STATES
    </country>
    <medlineta>
     Contraception
    </medlineta>
    <nlmuniqueid>
     0234361
    </nlmuniqueid>
    <issnlinking>
     0010-7824
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Contraceptive Agents, Female
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Hemoglobins
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      6533-00-2
     </registrynumber>
     <nameofsubstance>
      Norgestrel
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      797-63-7
     </registrynumber>
     <nameofsubstance>
      Levonorgestrel
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <citationsubset>
    J
   </citationsubset>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Blood Pressure
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Body Weight
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Contraceptive Agents, Female
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Hemoglobins
     </descriptorname>
     <qualifiername majortopicyn="N">
      metabolism
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Intrauterine Device Expulsion
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="Y">
      Intrauterine Devices, Medicated
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Levonorgestrel
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Norgestrel
     </descriptorname>
     <qualifiername majortopicyn="Y">
      administration &amp; dosage
     </qualifiername>
     <qualifiername majortopicyn="N">
      adverse effects
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Random Allocation
     </descriptorname>
    </meshheading>
   </meshheadinglist>
   <otherid source="CPFH">
    22588cr987
   </otherid>
   <otherid source="POP">
    00169990
   </otherid>
   <otherabstract type="PIP">
    <abstracttext>
     The use-effectiveness of an intrauterine contraceptive device releasing 20 mcg of levon ISZ orgestrel daily (Lng-IUD), and of a Nova T copper-releasing IUD, were studied in a randomized comparative mulicenter trial.  The Lng-IUD was inserted in 1821, and the Nova T in 937 women.  The 12-month net pregnancy rate with the Lng-IUD (0.1/100 women) was significantly lower than that with the Nova T (0.9/100).  Removal rates for menstrual problems and/or pain were similar for the 2 methods (net rates 7.5 and 8.7 respectively).  The 12-moth continuation rates were 82.2 for the Nova T and 79.7 for the Lng-IUD.  The reduction of the bleeding led to oligomenorrhea and amenorrhea in users of the Lng-IUD; the removal rate for these reasons was 1.4.  The removal rate for hormonal side effects with the Lng-IUD was 2.4.  Blood hemoglobin concentrations increased among users of the Lng-IUD and decreased among users of the Nova T.  The results show that the Lng-IUD was highly effective contraceptive method which reduced menstrual bleeding.  It it a promising alternative for women desiring a highly-effective method for long-term use.
    </abstracttext>
    <copyrightinformation>
     author's modified
    </copyrightinformation>
   </otherabstract>
   <keywordlist owner="PIP">
    <keyword majortopicyn="N">
     Biology
    </keyword>
    <keyword majortopicyn="Y">
     Clinical Research
    </keyword>
    <keyword majortopicyn="Y">
     Comparative Studies
    </keyword>
    <keyword majortopicyn="Y">
     Contraception
    </keyword>
    <keyword majortopicyn="N">
     Contraceptive Agents
    </keyword>
    <keyword majortopicyn="Y">
     Contraceptive Agents, Female
    </keyword>
    <keyword majortopicyn="Y">
     Contraceptive Agents, Progestin
    </keyword>
    <keyword majortopicyn="N">
     Contraceptive Methods
    </keyword>
    <keyword majortopicyn="N">
     Denmark
    </keyword>
    <keyword majortopicyn="N">
     Developed Countries
    </keyword>
    <keyword majortopicyn="N">
     Diseases
    </keyword>
    <keyword majortopicyn="Y">
     Eastern Europe
    </keyword>
    <keyword majortopicyn="N">
     Endocrine System
    </keyword>
    <keyword majortopicyn="N">
     Europe
    </keyword>
    <keyword majortopicyn="Y">
     Evaluation
    </keyword>
    <keyword majortopicyn="N">
     Examinations And Diagnoses
    </keyword>
    <keyword majortopicyn="N">
     Family Planning
    </keyword>
    <keyword majortopicyn="N">
     Finland
    </keyword>
    <keyword majortopicyn="Y">
     Genital Effects, Female
    </keyword>
    <keyword majortopicyn="N">
     Genitalia
    </keyword>
    <keyword majortopicyn="N">
     Genitalia, Female
    </keyword>
    <keyword majortopicyn="Y">
     Hormones--side effects
    </keyword>
    <keyword majortopicyn="N">
     Hungary
    </keyword>
    <keyword majortopicyn="Y">
     Iud
    </keyword>
    <keyword majortopicyn="Y">
     Iud, Copper Releasing
    </keyword>
    <keyword majortopicyn="Y">
     Levonorgestrel
    </keyword>
    <keyword majortopicyn="Y">
     Menstruation Disorders
    </keyword>
    <keyword majortopicyn="Y">
     Northern Europe
    </keyword>
    <keyword majortopicyn="N">
     Norway
    </keyword>
    <keyword majortopicyn="N">
     Physiology
    </keyword>
    <keyword majortopicyn="Y">
     Reproductive Control Agents
    </keyword>
    <keyword majortopicyn="N">
     Research Methodology
    </keyword>
    <keyword majortopicyn="Y">
     Research Report
    </keyword>
    <keyword majortopicyn="Y">
     Retention
    </keyword>
    <keyword majortopicyn="N">
     Scandinavia
    </keyword>
    <keyword majortopicyn="N">
     Studies
    </keyword>
    <keyword majortopicyn="N">
     Sweden
    </keyword>
    <keyword majortopicyn="N">
     Urogenital System
    </keyword>
   </keywordlist>
   <generalnote owner="PIP">
    TJ: CONTRACEPTION.
   </generalnote>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      1987
     </year>
     <month>
      8
     </month>
     <day>
      1
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      1987
     </year>
     <month>
      8
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      1
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      1987
     </year>
     <month>
      8
     </month>
     <day>
      1
     </day>
     <hour>
      0
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pubmed">
     3123132
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

